Pharmacovigilance and Drug Safety Software Market by Functionality (ADR Reporting Software, Drug Safety Audits Software, Issue Tracking Software, and Fully Integrated Software), by Delivery Mode (On-Premises and On-Demand), and by End-User (Pharma & Biotech Companies, Contract Research Organizations (CROS), Business Process Outsourcing (BPO) Firms, and Other Pharmacovigilance Service Providers)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers a forecast and an analysis of the pharmacovigilance and drug safety software market on a global and regional level. The study provides historical data for 2017 and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the pharmacovigilance and drug safety software market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pharmacovigilance and drug safety software market on a global level.

In order to give the users of this report a comprehensive view of the pharmacovigilance and drug safety software market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.


The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The study provides a decisive view of the pharmacovigilance and drug safety software market by segmenting the market based on functionality, delivery mode, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on functionality, the market is segmented into drug safety audits software, ADR reporting software, fully integrated software, and issue tracking software. By delivery mode, the market is segmented into on-premises and on-demand. By end-user, the market is segmented into contract research organizations (CROS), business process outsourcing (BPO) firms, pharma and biotech companies, and other pharmacovigilance service providers.

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global pharmacovigilance and drug safety software market include Oracle Corporation, ArisGlobal LLC, AB Cube, Max Delivery, Relsys, Sparta Systems, Inc., United BioSource Corporation, EXTEDO GmbH, and Ennov Solutions, Inc., among others.

This report segments the global pharmacovigilance and drug safety software market into:

Global Pharmacovigilance and Drug Safety Software Market: Functionality Analysis

	ADR Reporting Software 
	Drug Safety Audits Software 
	Issue Tracking Software 
	Fully Integrated Software 

Global Pharmacovigilance and Drug Safety Software Market: Delivery Mode Analysis

	On-Premises
	On-Demand

Global Pharmacovigilance and Drug Safety Software Market: End-User Analysis

	Pharma and Biotech Companies
	Contract Research Organizations (CROS)
	Business Process Outsourcing (BPO) Firms
	Other Pharmacovigilance Service Providers 

Global Pharmacovigilance and Drug Safety Software Market: Regional Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa